{"id":"W4386753453","doi":"10.1016/j.eururo.2023.08.001","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Hazard ratio; Metastatic Urothelial Carcinoma; Avelumab; Internal medicine; Urology; Maintenance therapy; Confidence interval; Progression-free survival; Surgery; Oncology; Bladder cancer; Urothelial carcinoma; Cancer; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002961504,0.0003532566,0.0007671763,0.0002405205,0.0001232401,0.00001514041,0.0001931771,0.0001129981,0.0002373736],"category_scores_gemma":[0.0001956196,0.0002962484,0.0002785586,0.0005250213,0.0002116102,0.0000804177,0.00008547298,0.0001912154,0.00004885276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006496701,"about_ca_system_score_gemma":0.00004662146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002079523,"about_ca_topic_score_gemma":0.000556108,"domain_scores_codex":[0.9977811,0.0001107056,0.0006892491,0.0007260874,0.0001992401,0.0004936063],"domain_scores_gemma":[0.9986855,0.0001669488,0.0002890822,0.0004956508,0.0002079343,0.0001549248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06799237,0.004169072,0.4632793,0.001257141,0.02010406,0.001708359,0.01959877,0.003081657,0.04145017,0.0006331939,0.08683124,0.2898947],"study_design_scores_gemma":[0.07181703,0.01600309,0.6875114,0.0002063666,0.00567067,0.0001311744,0.0004722837,0.04908725,0.01112545,0.00178641,0.1548196,0.001369323],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9703345,0.0006069888,0.01676313,0.0088469,0.0003147209,0.001057285,0.001228581,0.0001537893,0.000694059],"genre_scores_gemma":[0.9929025,0.0005681991,0.0007776586,0.001626203,0.0003621974,0.00007212501,0.0008577295,0.0001059978,0.002727436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2885254,"threshold_uncertainty_score":0.999949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01459571997533242,"score_gpt":0.2632105740065097,"score_spread":0.2486148540311772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}